Manufacturing Wire

The headline says U.S.-made chips are seeing a comeback and frames the development as relevant for investors.

The U.S. Commerce Secretary is urging Samsung and SK Hynix to expand semiconductor fabs in the United States.

Micron announced a strategic investment of up to $3 billion to strengthen the U.S. semiconductor ecosystem.

The headline reports that Comfort Systems USA is being highlighted as the lead name among three stock picks tied to the U.S. reshoring boom.

The headline reports an FAQ-style look at the status of U.S. pharmaceutical reshoring in 2026.

The headline reports a Q&A with Ryan Last on reshoring pharma and biotech manufacturing ahead of tariff deadlines this summer.

The headline frames American enterprise across a 250-year history and argues that its best work remains ahead.

Douglas Brown’s The Black Book of Reshoring was named a finalist in the Business category of the 2026 International Book Awards.

The headline reports on realistic timelines for reshoring pharmaceutical manufacturing.

The headline reports that the U.S. reshoring story is moving from promise toward progress and is finding cyclical footing.

The headline reports that Gerren McHam is discussing the future of U.S. pharma reshoring.

Lovesac is reshoring production of its Sactionals to the United States in 2026.

The headline reports that Gerren McHam examines what effective pharmaceutical reshoring requires.

U.S. factory construction is continuing to decline despite a tariff push intended to support domestic manufacturing. The headline frames the expected reshoring boom as weaker than anticipated.

The headline reports that three U.S. stocks are positioned around reshoring and supported by domestic manufacturing demand.

The headline reports that three U.S. stocks could benefit from reshoring and higher tariffs.

The headline reports that new U.S. planning projects are providing signals about what to expect in 2026.

Coherent and NVIDIA have broken ground on a US$650m facility in Texas.

The headline reports that Intel shares surged on news of an Apple chip deal, with Bernstein’s Stacy Rasgon saying investors are treating the move as a bet on Intel’s foundry business.

The headline reports that a Texas plant is set to quadruple output of chips used in advanced computing.